Technology & Software Global On demand · 24-48h

Global AI In Predictive Toxicology Market Strategic Research Report

Global AI In Predictive Toxicology Market Strategic Research…
$3,500 USD
Market Research Reports
Strategic Research Report
Global AI In Predictive Toxicology Market
$2352025
28.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Machine Learning, Natural Language Processing, Computer Vision

By Application: Pharmaceutical & Biotechnology, Chemical & Cosmetics, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: BenevolentAI, Exscientia, Instem, Dassault Systèmes, Evotec, Simulations Plus, Schrodinger, Insilico Medicine, Chemcopilot, Inotiv

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 91 pages
Market size 2025
$235
Million USD
Forecast CAGR
28.9%
2025-2032
Forecast 2032
$1389.4
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global AI In Predictive Toxicology market size is predicted to grow from US$ 235 million in 2025 to US$ 1,366 million in 2032; it is expected to grow at a CAGR of 28.9% from 2026 to 2032.

Artificial Intelligence (AI) is one of the most innovative technologies that has revolutionized the world of toxicology in recent years. The intersection of artificial intelligence and toxicology has led to the development of a revolutionary method called Predictive Toxicology. In this method, computer models use data analytics and machine learning to predict the possible negative effects of chemicals. This convergence of modern technologies has enormous promise in accelerating the risk assessment process, reducing dependency on traditional experimental approaches, and expanding our understanding of the complicated link between chemical exposure and biological reactions.

In recent times, machine learning has become increasingly prominent in predictive toxicology as it has shifted from in vivo studies towards in silico studies. Currently, in vitro methods together with other computational methods such as QSAR modelling and ADME calculations are being used. In predictive toxicology SVMs, RF and DTs are the dominant machine learning methods due to the characteristics of the data available.

Natural Language Processing (NLP) represents another critical AI domain for toxicology, extracting information from scientific literature, clinical reports, and adverse event databases. Recent advancements in biomedical NLP have enabled the automated extraction of toxicity relationships from millions of publications, significantly enhancing the knowledge base available for predictive models.

The market for AI in predictive toxicology was steadily growing due to increased awareness of the potential of AI-driven tools in assessing chemical safety and toxicity. This growth was driven by the need for faster and more accurate methods to evaluate the safety of chemicals used in various industries, including pharmaceuticals, cosmetics, chemicals, and agriculture. Advancements in AI algorithms, machine learning models, and data analytics were driving innovation in predictive toxicology. These advancements aimed to enhance the accuracy and efficiency of toxicity predictions, leveraging large datasets and high-throughput screening methods. Opportunities existed for AI-driven predictive toxicology tools to streamline drug discovery, chemical safety assessments, and reduce the reliance on animal testing. Additionally, expanding applications in assessing environmental toxicity and regulatory compliance presented growth opportunities.

This report presents a comprehensive overview of the global AI In Predictive Toxicology market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Machine Learning
  • Natural Language Processing
  • Computer Vision

Segment by players, this report covers

  • BenevolentAI
  • Exscientia
  • Instem
  • Dassault Systèmes
  • Evotec
  • Simulations Plus
  • Schrodinger
  • Insilico Medicine
  • Chemcopilot
  • Inotiv

Segment by Application

  • Pharmaceutical & Biotechnology
  • Chemical & Cosmetics
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global AI In Predictive Toxicology market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pharmaceutical & Biotechnology, Chemical & Cosmetics, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global AI In Predictive Toxicology Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 28.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$235
2025
Forecast
$1389.4
2032
CAGR
28.9%
2025–2032
Regions
5
global
Key companies
BenevolentAIExscientiaInstemDassault SystèmesEvotecSimulations PlusSchrodingerInsilico Medicine
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Machine LearningNatural Language ProcessingComputer Vision
By Application
Pharmaceutical & BiotechnologyChemical & CosmeticsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Machine Learning
  • 3.1.3 Natural Language Processing
  • 3.1.4 Computer Vision
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pharmaceutical & Biotechnology
  • 4.1.3 Chemical & Cosmetics
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 BenevolentAI
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Exscientia
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Instem
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Dassault Systèmes
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Evotec
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Simulations Plus
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Schrodinger
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Insilico Medicine
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Chemcopilot
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Inotiv
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global AI In Predictive Toxicology market?
The global AI In Predictive Toxicology market is estimated at US$ 235 million in 2025 (base year) and is projected to reach US$ 1.37 billion by 2032.
How fast is the AI In Predictive Toxicology market expected to grow?
The market is expected to grow at a CAGR of 28.9% from 2026 to 2032, expanding from US$ 235 million in 2025 to US$ 1.37 billion in 2032, roughly 5.8 times its base-year value.
What does the AI In Predictive Toxicology market cover?
Artificial Intelligence (AI) is one of the most innovative technologies that has revolutionized the world of toxicology in recent years. The intersection of artificial intelligence and toxicology has led to the development of a revolutionary method called Predictive Toxicology. In this method, computer models use data analytics and machine learning to predict the possible negative effects of chemicals.
What are the main segments of the AI In Predictive Toxicology market by type?
By type, the market is segmented into Machine Learning, Natural Language Processing and Computer Vision.
Which applications drive demand in the AI In Predictive Toxicology market?
Key applications covered include Pharmaceutical & Biotechnology, Chemical & Cosmetics and Others.
Who are the key players in the AI In Predictive Toxicology market?
Key players profiled include BenevolentAI, Exscientia, Instem, Dassault Systèmes, Evotec, Simulations Plus, Schrodinger and Insilico Medicine, among 10 companies covered in total.
Which regions and countries are covered for AI In Predictive Toxicology?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the AI In Predictive Toxicology market?
The market for AI in predictive toxicology was steadily growing due to increased awareness of the potential of AI-driven tools in assessing chemical safety and toxicity.
Who should buy the AI In Predictive Toxicology market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceutical & Biotechnology, Chemical & Cosmetics and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the AI In Predictive Toxicology market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.